Composition: 1 ml of sterile solution contains; 0.1 ± 0.01 mg of CaCl2 and 10-7-10-8 mg of a protein-peptide complex isolated from pancreatic tissue of young gobies.
The physiological effect of viorgon-8 is associated with its property to additionally activate cellular sources of regeneration in tissue, maintain the viability of cells, including islets of Langerhans, as well as adhesive interactions between them.
Recommendations for use. Viorgon 8 is recommended for pancreatic diseases (together with viorgon 1 and 7), including, in the rehabilitation period after pancreatitis, type 2 diabetes. Viorgon-8 is combined with other viorgons (especially Viorgon-1 and Viorgon-7).
Mode of application
Viorgon can be taken by application to the mucous membrane, intranasally: by instilling into the nasal cavity, or sublingually: by ordering under the tongue. In this case, the dosage starts from 3 drops.
Viorgon can be taken orally, diluting in water at the rate of at least 8-10 drops per 100 ml of water. Drink at least 20-30 minutes before eating or 2 hours after.
A positive effect is observed from the use of 3 or more times a day. An overdose of viorgon preparations is excluded, it is allowed to take as many times a day as they will favorably affect the well-being. The addictive effect is also absent.
The interval between the various viorgons is at least 10 minutes.